Literature DB >> 17553817

Which is the better pathological prognostic factor, the Nottingham histological grade or the Japanese nuclear grade? A large scale study with a long-term follow-up.

Yoshiro Otsuki1, Shin-ichi Shimizu, Kaori Suwa, Masayuki Yoshida, Masao Kanzaki, Hiroshi Kobayashi.   

Abstract

BACKGROUND: We compared the Nottingham histological grade (H-grade) and the Japanese nuclear grade (N-grade) to select the better prognostic factor for breast cancers.
METHODS: The series included 1786 patients with breast cancers with the exception of non-invasive and stage 4 cancers. They were classified according to the H- and N-grade. We analyzed their survival curves and also performed multivariate Cox regression analyses.
RESULTS: According to the H-grade classification, 476 cases were grade 1, 647 cases were grade 2 and 663 cases were grade 3. According to the N-grade, 381 cases were grade 1, 215 cases were grade 2, and 1129 cases were grade 3. In the survival curves of those cases with lymph node metastases (N+) and recurrent cases, there were statistically significant differences in different categories of the H-grades, but not in the N-grades. The survival curves of all the cases and those cases without lymph node metastases (N-) always exhibited statistically significant differences. According to the 2003 St Gallen consensus, the N- group was classified as a minimal risk and an average risk groups. Both H- and N-grade exhibited statistically significant differences between the minimal risk and the average risk groups in the disease-free survival. The multivariate analyses proved that the H-grade was a statistically significant prognostic factor in all the cases and N+ group, but the N-grade was not significant in any of the studies.
CONCLUSIONS: The H-grade is clearly proved to be a more significant prognostic factor for wider stage cases than the N-grade.

Entities:  

Mesh:

Year:  2007        PMID: 17553817     DOI: 10.1093/jjco/hym026

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Node-Negative Breast Cancer: Which Patients Should Be Treated?

Authors:  Marcus Schmidt
Journal:  Breast Care (Basel)       Date:  2008-08-20       Impact factor: 2.860

2.  New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.

Authors:  Tadahiro Nozoe; Emiko Mori; Tomohiro Iguchi; Takahiro Ezaki
Journal:  Int Surg       Date:  2013 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.